Prosecution Insights
Last updated: May 29, 2026

The Cleveland Clinic Foundation

18 pending office actions • 13 art units • 18 examiners • 0 of 18 (0%) have an AI response strategy ready • 31 patents granted in the last 365 days

Portfolio Summary

18
Total Pending OAs
14
Non-Final OAs
4
Final Rejections
0
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 17 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

6
Overdue
1
Due this week
8
Due this month
2
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 17 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (6)Due ≤ 7 days (1)Due ≤ 30 days (8)Due ≤ 60 days (2)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
15
Medium (83%)
1
Easy (6%)
2
Unknown (11%)

Rejection Statute Mix

BucketCases
§103 only13 (72%)
§102 only2 (11%)
§112 only1 (6%)
No statute on record2 (11%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

12
Life Sciences
67% of docket
0
Information Tech
0% of docket
1
Communications
6% of docket
0
Semiconductors
0% of docket
5
Mechanical / Eng
28% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

180 h
Manual time on pending OAs
36 h
Time saved (low, 20%)
63 h
Time saved (mid, 35%)
1.6 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
SHENG, CHAO 1 63.0% +27.4%
PAHAKIS, MANOLIS Y 1 68.5% +50.4%
JOHNSON, NICOLE F 1 87.4% +7.2%
FETTEROLF, BRANDON J 1 49.5% +14.6%
BARSKY, JARED 1 50.2% +23.0%
ENGLISH, CONNOR KENNEDY 1 55.9% +55.6%
CHATTIN, AMY MARIE 1 74.3% +39.1%
DUFFY, BRADLEY 1 54.4% +45.4%
CORNET, JEAN P 1 42.0% +47.8%
GILL, RACHEL B 1 65.6% +27.7%

Quick Wins (1)

Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18599646 STABILIZING FRAMES AND METHODS OF POSITIONING WITH A STABILIZING FRAME JOHNSON, NICOLE F 8d

Interview Candidates (9)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.

App #TitleExaminerDue in
18040531 MULTI-EPITOPE VACCINE GILL, RACHEL B 24d overdue
18169293 AMHR2-ED CANCER VACCINE FORMULATIONS DUFFY, BRADLEY 23d overdue
18570520 PROTEASE INHIBITORS AND METHODS OF USE FETTEROLF, BRANDON J 10d overdue
18713215 SYSTEM AND PROCESS FOR CLOSED-LOOP DEEP BRAIN STIMULATION PAHAKIS, MANOLIS Y 12d
18546245 TREATING VIRAL INFECTION WITH NMD INHIBITORS ENGLISH, CONNOR KENNEDY 12d
18556564 PROTEASE INHIBITORS AND METHODS OF USE BARSKY, JARED 13d
19055951 SYSTEMS AND METHODS FOR USE WITH MRI-GUIDED FOCUSED ULTRASOUND SHENG, CHAO 20d
18041249 BACE1 INHIBITOR TREATMENT FOR SUPPRESSING CYTOKINE STORM CORNET, JEAN P 60d

Top Art Units

Art UnitApps
1628 3
3796 2
1626 2
1643 2
3797 1
1625 1
1671 1
3783 1
2672 1
1685 1

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19055951 SYSTEMS AND METHODS FOR USE WITH MRI-GUIDED FOCUSED ULTRASOUND SHENG, CHAO 3797 §103 Non-Final OA 20d Pending Feb 18, 2025
18713215 SYSTEM AND PROCESS FOR CLOSED-LOOP DEEP BRAIN STIMULATION PAHAKIS, MANOLIS Y 3796 §103 Non-Final OA 12d Pending May 24, 2024
18599646 STABILIZING FRAMES AND METHODS OF POSITIONING WITH A STABILIZING FRAME JOHNSON, NICOLE F 3796 §102 Non-Final OA 8d Pending Mar 08, 2024
18570520 PROTEASE INHIBITORS AND METHODS OF USE FETTEROLF, BRANDON J 1626 §102 Non-Final OA 10d overdue Pending Dec 14, 2023
18556564 PROTEASE INHIBITORS AND METHODS OF USE BARSKY, JARED 1628 Other Non-Final OA 13d Pending Oct 20, 2023
18546245 TREATING VIRAL INFECTION WITH NMD INHIBITORS ENGLISH, CONNOR KENNEDY 1625 §103 Non-Final OA 12d Pending Aug 11, 2023
18252928 ANTI-CD6 ANTIBODY CONJUGATES FOR TREATING T-CELL MEDIATED DISORDERS AND T-CELL LYMPHOMA/LEUKEMIA CHATTIN, AMY MARIE 1643 §112 Non-Final OA Pending May 15, 2023
18169293 AMHR2-ED CANCER VACCINE FORMULATIONS DUFFY, BRADLEY 1643 Other Non-Final OA 23d overdue Pending Feb 15, 2023
18041249 BACE1 INHIBITOR TREATMENT FOR SUPPRESSING CYTOKINE STORM CORNET, JEAN P 1628 §103 Final Rejection 60d Pending Feb 10, 2023
18040531 MULTI-EPITOPE VACCINE GILL, RACHEL B 1671 §103 Non-Final OA 24d overdue Pending Feb 03, 2023
18003807 COMPOUNDS AND METHODS OF PROMOTING OLIGODENDROCYTE PRECURSOR DIFFERENTIATION LEE, CHIHYI NMN 1628 §103 Non-Final OA 6d Pending Dec 29, 2022
18001832 TREATMENT OF VIRAL INFECTIONS WITH ESTROGEN RECEPTOR MODULATORS AND ANTI-INFLAMMATORY AGENTS HAVLIN, ROBERT H 1626 §103 Final Rejection 45d overdue Pending Dec 14, 2022
17927536 AMBULATORY FLUID DRAINAGE AND COLLECTION DEVICE FREDRICKSON, COURTNEY B 3783 §103 Non-Final OA 33d Pending Nov 23, 2022
17971065 RADIOMICS SIGNATURES FOR PATHOLOGIC CHARACTERIZATION OF STRICTURES ON MR AND CT ENTEROGRAPHY YENTRAPATI, AVINASH 2672 §103 Final Rejection 59d overdue Pending Oct 21, 2022
17795465 DISEASE DETECTION AND TREATMENT BASED ON PHENYLACETYL GLUTAMINE LEVELS FONSECA LOPEZ, FRANCINI ALVARENGA 1685 §103 Non-Final OA 27d Pending Jul 26, 2022
17783359 APPARATUS AND METHOD FOR USE OF FLUID FLOW DEVICE LE, QUYNH DAO 3781 §103 Non-Final OA 31d overdue Pending Jun 08, 2022
17488384 RAPID TEST SYSTEM FOR VIRAL AND BACTERIAL INFECTIONS JADHAO, SAMADHAN JAISING 1672 §103 Non-Final OA 12d Pending Sep 29, 2021
17047497 METHODS AND COMPOSITIONS FOR TH9 CELL MEDIATED CANCER TREATMENT ESSEX, LAURA ANN 1675 §103 Final Rejection 13d Pending Oct 14, 2020

Managing The Cleveland Clinic Foundation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month